RT-155

14th International Congress
THE "NEW FRONTIERS"
OF ARRHYTHMIAS 2000

Jan. 29 - Feb. 5, 2000
Marilleva, Trento, Italy

RT-155

Among congenital cardiomyopathies with a peripheral myopathy, Steinert’s cardiomyopathy shows the highest risk of sudden death. Clinical evaluation and follow-up of five families

Franco Naccarella*, Fabio Iachetti***, Giovannina Lepera, Antonella Bartoletti, Sandra Gabellini**, Mauro Gatti, Mario Coluccini, Patrizia Bertaccini****, Giuseppe Novelli***, Bruno Dallapiccola***.
*Cardiology Department, Azienda USL della Citta di Bologna, Bologna, **Neurology, Maggiore Hospital, Bologna, ***Human Genetic, Universities of Tor Vergata and La Sapienza, Roma, ****Opthalmology Department, University of Bologna, Italy

Abstract

Among congenital cardiomyopathies, the most frequently observed are primary dilated cardiomyopathies (PDC) and dilated cardiomyopathies (DC) in the context of a peripheral myopathy. The most frequently observed DC is Steinert’ s myopathy-cardiomyopathy (SMC). This condition manifests itself as a primary cardiomyopathy, complicated by ventricular arrhythmias and/ or progressive intraventricular conduction disturbances.
We observed and followed up, over time, 5 patients and their families for a total of 42 members, 3 of them known to carry the SMC. Coversely, two of them were evaluated, mainly for ventricular arrhythmias and different intraventricular conduction disturbances and previously undiagnosed SMC. Clinical cardiovascular evaluation included bidimensional echo, 24-hour 12 leads electrocardiography and genetic screening (GS). GS was obtained to confirm the diagnosis and the severity of the disease which is related, as already known, to CTG (cytosine-thymine-guanine) triplets repetitions number. Furthermore, we evaluated the severity of the associated DC and its evolution over time, which was rapidly progressive and at high risk of SD. In fact, a high incidence of DC was observed in the considered families (45% of the subjects were affected). Of these 7/19 (37%) showed a clinical picture of CHF at the time of clinical evaluation. Intraventricular conduction delays were observed in 12/42 (29%). Frequent ventricular arrhythmias were found in 23/42 (55%) and major ventricular arrhythmias (VT/VF) were observed in 3/19 (16%). SD was frequently observed in the different considered families.
Thus, DC is frequently observed in SMC and requires accurate evaluation and often non pharmacological therapy. In conclusion, in SMC, cardiac involvement seems to be more severe than the peripheral myopathy itself. These patients and their family members should be carefully followed-up, over time, to institute the appropriate non pharmacological therapy (permanent pacing and ICD when required.

Key Words


 

forward

CARDIOnet® - registered trade mark name
Copyright © 1996-2000 by CARDIOnet. All rights reserved.